The continued rally of cannabis stocks showed no signs of slowing down today, with industry leaders rallying 10% to 33%. This reversal resulted from the culmination of the MORE Act passing House judicial review, although it still needs to head for a full House vote.
Canopy Growth rallied 30.9% over the past two trading days, with the Bank of America upgrade costing short sellers over a quarter billion dollars.
Gainers
- Aurora Cannabis ACB shares rose 18.02%, to close at $3.12.
- Aphria APHA shares gained 9.62%, closing at $4.96.
- Canopy Growth CGC shares increased by 15.02% to close at $20.29.
- Cronos Group CRON shares rose 10.92%, to close at $7.62.
- CannTrust Holdings CTST shares increased by 7.56% to close at $0.97.
- Fire & Flower Holdings FFLWF shares rose 0.65%, to close at $0.77.
- GW Pharmaceuticals GWPH shares rose 0.15%, to close at $99.36.
- HEXO HEXO shares rose 33.68%, to close at $2.54.
- Harvest Health HRVSF shares gained 2.9%, closing at $2.84.
- Akerna KERN shares gained 12.63%, closing at $5.35.
- KushCo Holdings KSHB shares rose 3.98%, to close at $1.83.
- Alcanna LQSIF shares gained 13.73%, closing at $3.48.
- MediPharm Labs MEDIF shares increased by 4.27% to close at $3.17.
- OrganiGram Holdings OGI shares gained 16.26%, closing at $2.86.
- Planet 13 Holdings PLNHF shares gained 2.9%, closing at $1.64.
- Pyxus International PYX shares increased by 3.77% to close at $8.26.
- Sundial Growers SNDL shares rose 15.83%, to close at $3.22.
- Supreme Cannabis Co SPRWF shares gained 14.34%, closing at $0.59.
- Tilray TLRY shares rose 7.22%, to close at $22.43.
- Valens Groworks VGWCF shares rose 3.75%, to close at $2.55.
- cbdMD YCBD shares rose 5.1%, to close at $3.30.
- Zynerba Pharmaceuticals ZYNE shares rose 2.75%, to close at $6.73.
Losers
- Columbia Care CCHWF shares fell 10.54% to close at $2.32.
- Cresco Labs CRLBF shares dropped by 1.15%, to close at $6.02.
- Greenlane Holdings GNLN shares tumbled by 0.29%, eventually closing at $3.38.
- Innovative Industrial IIPR shares tumbled by 0.19%, eventually closing at $79.85.
- MedMen Enterprises MMNFF shares fell 2.93% to close at $0.65.
- Therapix Biosciences TRPX shares tumbled by 0.67%, eventually closing at $1.49.
Related Links:
Treading The Muddied Waters Of CBD Standards For Marketing And Safety
Green Thumb Industries Posts Q3 Revenue Of $68M: 'Positioned To End 2019 On A Strong Note'
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.